CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc. (NASDAQ:CBLL) on August 5, setting a price target of $21.00.
A medical technician in a lab coat overseeing a complex piece of healthcare technology equipment.
The rating update came after CeriBell, Inc. reported its Q2 results on the same day, with total revenue for the quarter reaching $21.2 million and reflecting a 38% growth compared to the same quarter last year.
CeriBell, Inc. also attained a gross margin of 88% in Q2 2025, and ended the quarter with 584 total active accounts.
CeriBell, Inc. is a commercial-stage medical technology company that engages in the diagnosis and management of patients with serious neurological conditions. The company’s products include Point-of-Care EEG, EEG Portal, and Clarity.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
